About
Michael Lobel is an entrepreneur and company builder in the healthy-aging and brain-performance sector, best known as a co-founder of Aviv Scientific. Aviv Scientific develops hyperbaric-medicine-based programs and clinics focused on age-related cognitive and functional decline, and the company raised a $40 million Series B in 2021. Outside the company, Lobel also serves in nonprofit leadership as Audit Committee Chair and a director of American Friends of the Hebrew University.
Areas of interest
longevityhealthy agingbrain healthhyperbaric oxygen therapycognitive performancemedical clinicshealth dataomics